Immediate Impact
3 from Science/Nature 56 standout
Citing Papers
Catalytic Asymmetric Construction of Chiral Polysubstituted 3-Azabicyclo[3.1.1]heptanes by Copper-Catalyzed Stereoselective Formal [4π+2σ] Cycloaddition
2024 Standout
A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells
2024 Standout
Works of Emerson A. Lim being referenced
First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy
2022
Abstract CT026: Evidence of immune activation in the first-in-human Phase Ia dose escalation study of the adenosine 2a receptor antagonist, AZD4635, in patients with advanced solid tumors
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Emerson A. Lim | 393 | 156 | 159 | 217 | 207 | 59 | 978 | |
| Eric Wehrenberg-Klee | 456 | 164 | 231 | 119 | 82 | 41 | 822 | |
| Nima Nabavizadeh | 329 | 370 | 236 | 80 | 297 | 72 | 1.0k | |
| Zhe Tang | 249 | 275 | 48 | 253 | 204 | 54 | 911 | |
| Leonora S. F. Boogerd | 319 | 298 | 141 | 406 | 274 | 32 | 1.0k | |
| Ryoichi Miyamoto | 439 | 231 | 44 | 114 | 268 | 49 | 746 | |
| Frederik Wenz | 252 | 239 | 138 | 116 | 154 | 57 | 950 | |
| Priyanka Jha | 148 | 110 | 189 | 95 | 227 | 79 | 1.1k | |
| Michele Lamuraglia | 184 | 275 | 292 | 227 | 67 | 39 | 817 | |
| Dong Zheng | 198 | 221 | 80 | 66 | 227 | 49 | 1.1k | |
| Tatsuya Manabe | 532 | 154 | 94 | 86 | 311 | 62 | 1.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...